Skip to content Skip to footer
Ukoniq: Benefits, Reviews, Info, Side Effects!
Rx Details
Ukoniq
Umbralisib, TGR-1202
Ukoniq is the chemical name for umbralisib.
Prescription
Medication
Drugs
Prescription Only
treatment of certain types of lymphoma, inhibition of cancer cell growth, reduction of tumor size, management of relapsed or refractory marginal zone lymphoma, management of relapsed or refractory follicular lymphoma
Abdominal Pain, Anemia, Decreased Appetite, Diarrhea, Fatigue, Increased Liver Enzymes, Nausea, Neutropenia, Rash, Thrombocytopenia, Vomiting
Ukoniq (umbralisib) is a medication that was used for the treatment of certain types of lymphoma. However, it’s important to note that as of June 2022, the manufacturer voluntarily withdrew Ukoniq from the U.S. market due to safety concerns. Prior to its withdrawal, the typical dosage for Ukoniq was 800 mg taken orally once daily with food. Always consult a healthcare professional for the most accurate and personalized information regarding medication dosages.
Chronic lymphocytic leukemia, small lymphocytic lymphoma, marginal zone lymphoma
Ukoniq has a favorable safety profile.
No Interactions Reported
$15.00 – $20.00
$15,000 for a 30day supply.

A Synopsis of

Ukoniq

Ukoniq is a novel medication that has been approved by the FDA for the treatment of certain types of lymphoma. This drug belongs to a class of medications known as PI3K inhibitors, which work by targeting specific pathways involved in the growth and survival of cancer cells.

Ukoniq has shown promising results in clinical trials, demonstrating its ability to effectively shrink tumors and improve overall survival rates in patients with relapsed or refractory lymphoma. It is specifically indicated for use in patients with relapsed or refractory marginal zone lymphoma (MZL) or follicular lymphoma (FL) who have received at least two prior therapies.

As with any medication, Ukoniq does come with potential side effects that should be discussed with your healthcare provider. Common side effects may include diarrhea, nausea, fatigue, and elevated liver enzymes. It is important to report any side effects to your healthcare provider promptly to ensure proper management and monitoring.

It is crucial to follow your healthcare provider’s instructions carefully when taking Ukoniq, including the recommended dosage and schedule. It is also important to inform your healthcare provider of any other medications or supplements you may be taking, as they could interact with Ukoniq and affect its effectiveness.

Overall, Ukoniq represents a significant advancement in the treatment of certain types of lymphoma and offers new hope for patients who have not responded to other therapies. If you have been prescribed Ukoniq, be sure to discuss any questions or concerns with your healthcare provider to ensure the best possible outcomes.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN